ArcherDX: Invitae Completes Transaction with ArcherDX to Bring Comprehensive Cancer Genetics and Precision Oncology to Patients Worldwide
-- World-class germline and somatic testing, liquid biopsy and tissue genomic profiling, now delivered from a single platform with unrivaled breadth and flexibility --
Read full article »
ArcherDX is a bioinformatics company that develops and commercializes NGS-based gene fusion detection assays for oncology applications.
Read more